STOCK TITAN

GELSTAT CORP - $GSAC STOCK NEWS

Welcome to our dedicated page for GELSTAT news (Ticker: $GSAC), a resource for investors and traders seeking the latest updates and insights on GELSTAT stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect GELSTAT's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of GELSTAT's position in the market.

Rhea-AI Summary
GelStat's subsidiary, GSAC Engineering, acquires Duos Technologies' iCAS business line, expanding into new products and contracts in the industrial security market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.11%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.26%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-16.22%
Tags
GELSTAT CORP

OTC:GSAC

GSAC Rankings

GSAC Stock Data

5.10M
9.52%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
United States of America
Palm City

About GSAC

gelstat corporation is an investment banking/venture company located in 1650 e 82nd st ste 1040, minneapolis, minnesota, united states.